Here we evaluate the Bax, Bcl-2 and Bax/Bcl-2 ratio, as markers of the apoptotic status of circulating leukocytes of IBD patients, in order to explore if any of these markers are able to distinguish remission from relapse in IBD patients. The gene discussed is BCL2; the disease is inflammatory bowel disease.